REGEN BIOPHARMA, INC. (RGBP) Operating margin 2017–2025
REGEN BIOPHARMA, INC. (RGBP) operating margin by fiscal year — reported operating income divided by reported revenue.
-143.1%FY2025 · since FY2017: -2282.6% → -143.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -143.1% | +33.3 pp |
| FY2024 | -176.4% | +114.0 pp |
| FY2023 | -290.4% | -19.8 pp |
| FY2022 | -270.6% | +57.5 pp |
| FY2021 | -328.1% | -137.8 pp |
| FY2020 | -190.3% | +497.7 pp |
| FY2019 | -688.0% | +737.8 pp |
| FY2018 | -1425.8% | +856.8 pp |
| FY2017 | -2282.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice